Commodore Capital’s Mersana Therapeutics MRSN Stock Holding History

Commodore Capital’s Portfolio MRSN Stock Details MRSN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell
2023 Q3	$2.85M	Buy
2021 Q3	–	Sell
2021 Q2	$5.83M	Hold
2021 Q1	$6.95M	Buy
2020 Q4	$4.23M	Buy